Gene M. Dubowchik
Gene M. Dubowchik
Senior Vice President, Molecular Technologies, Biohaven Pharmaceuticals
Elected to the Academy in 2025

Education

Franklin and Marshall College, 1981, AB, Chemistry & History; Princeton University, 1983, MA, Chemistry; Princeton University, 1987, PhD, Chemistry

Professional Areas

Small molecule medicinal chemistry, primarily in the areas of neuroscience, oncology, and immunology, biologics drug discovery, especially in the Areas of antibody drug conjugates (ADCs) for oncology and immunological disease, and extracellular degraders – both small molecule and protein-based.

Citation

For seminal contributions to antibody-drug conjugate (ADC) linker design that is represented in five marketed Oncology ADC drugs and his role as a co-inventor of two FDA approved CNS migraine drugs Nurtec® (rimegepant) and Zavzpret® (zavegepant), conferring international stature, reputation and visibility in the medicinal chemistry community.